Skip to main content
Premium Trial:

Request an Annual Quote

Purely Proteins Licenses Database to Cytomyx

NEW YORK, Dec. 12-The British company Purely Proteins has licensed its gene and protein database to Cytomyx, the company said today.

 

Cytomyx obtained a license to use the TargetBASE Plus database for data regarding G-protein coupled receptors.

 

Purely Proteins' databases include both public and proprietary information about proteins, targets and ligands. Its TargetBASE database includes nucleotide, EST, and protein information organized in gene families. The company is based in Cambridge, UK.

 

Cytomyx develops gene- and protein-based tools for pharmaceutical research. It is also based in Cambridge.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.